Kci Medical Gmbh
Kci Medical Gmbh is a Private limited company (Ltd.) registered in Switzerland under CHE106071341, and its current status with Zefix — Swiss Central Business Names Index is active. The company was incorporated on 2 June 1998 and lists its registered address as Rüschlikon, Switzerland. 2 shareholders are on record for Kci Medical Gmbh, including at least one natural person recorded as a direct holder; the filing carries no beneficial-ownership flag, so that holder is noted here as a recorded shareholder rather than a confirmed ultimate beneficial owner (UBO). This profile is sourced directly from Zefix — Swiss Central Business Names Index and was last updated on 3 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
2
Two shareholders are currently on record for Kci Medical Gmbh, reflecting the Aktienbuch (share register) maintained under Article 686 of the Swiss Code of Obligations rather than a public filing.
The largest of these is Solventum, holding 100% — a majority holding — followed by Solventum International Holdings Limited at 100%.
1 shareholder shown is a company, so the ownership chain continues above this level for that holding; the other 1 is recorded as direct individual holder, though the record carries no UBO/PSC flag confirming beneficial-owner status.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Solventum | 100% | Zefix — Swiss Central Business Names Index | |
| Solventum International Holdings Limited | 100% | Zefix — Swiss Central Business Names Index |
Officers
3
Three officers are currently on record for Kci Medical Gmbh, filed with Zefix — Swiss Central Business Names Index. Loredana Bacher serves as Vorsitzende Der Geschäftsführung; Michael Klippe serves as Geschäftsführer; Regula Patroncini serves as Geschäftsführerin.
Management authority at Kci Medical Gmbh sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
Kci Medical Gmbh sits 4 levels below its ultimate parent, Solventum Corporation, registered in United States. Immediately above Kci Medical Gmbh is Solventum International Holdings LIMITED, holding 100% as filed in Kci Medical Gmbh's own shareholder record with Zefix — Swiss Central Business Names Index. Solventum Corporation sits further up the chain, a link derived by walking shareholder filings across jurisdictions rather than stated in a single document.
Solventum Corporation
United States
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns Kci Medical Gmbh?
Two shareholders are currently on record for Kci Medical Gmbh, reflecting the Aktienbuch (share register) maintained under Article 686 of the Swiss Code of Obligations rather than a public filing. The largest of these is Solventum, holding 100% — a majority holding — followed by Solventum International Holdings Limited at 100%. 1 shareholder shown is a company, so the ownership chain continues above this level for that holding; the other 1 is recorded as direct individual holder, though the record carries no UBO/PSC flag confirming beneficial-owner status.
Who is Kci Medical Gmbh's UBO (Ultimate Beneficial Owner)?
At least one shareholder recorded for Kci Medical Gmbh is a natural person. The record carries no dedicated UBO/PSC flag, so that holder is stated here as a recorded shareholder rather than a confirmed Ultimate Beneficial Owner (UBO).
How many shareholders does Kci Medical Gmbh have on record?
2 shareholders are shown on record for Kci Medical Gmbh.
What is Kci Medical Gmbh's company registration number?
Kci Medical Gmbh's registration number is CHE106071341, filed with Zefix — Swiss Central Business Names Index in Switzerland. Its current status on the register is active.
Is Kci Medical Gmbh still an active company?
Kci Medical Gmbh's status on Zefix — Swiss Central Business Names Index is listed as active.
When was Kci Medical Gmbh incorporated?
Kci Medical Gmbh was incorporated on 2 June 1998, according to Zefix — Swiss Central Business Names Index.
What is Kci Medical Gmbh's registered address?
The registered address on file for Kci Medical Gmbh is Rüschlikon, Switzerland.
Who are the officers/directors of Kci Medical Gmbh?
Three officers are currently on record for Kci Medical Gmbh, filed with Zefix — Swiss Central Business Names Index. Loredana Bacher serves as Vorsitzende Der Geschäftsführung; Michael Klippe serves as Geschäftsführer; Regula Patroncini serves as Geschäftsführerin. Management authority at Kci Medical Gmbh sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does Kci Medical Gmbh have a parent company or subsidiaries?
Kci Medical Gmbh sits 4 levels below its ultimate parent, Solventum Corporation, registered in United States.
Can Zavia monitor changes to Kci Medical Gmbh's ownership over time?
This profile reflects a point-in-time snapshot from Zefix — Swiss Central Business Names Index. Zavia's monitoring API can track changes to Kci Medical Gmbh's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access Kci Medical Gmbh's data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including Switzerland, so records like Kci Medical Gmbh's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Zefix — Swiss Central Business Names Index and was last synced on 3 October 2026.